Abstract:Background and aim: Traumatic brain injury (TBI), a leading cause of high morbidity and mortality, represents a significant global public health challenge. Currently, no effective treatment for TBI exists. Curcumin, an active compound extracted from the root of Curcuma longa , has demonstrated neuroprotective properties both in vitro and in vivo . Notably, it has shown potential in reducing oxidative stress and inflammation and enhancing redox balance. This paper conducts a systematic review and meta-analysis to explore curcumin's role in TBI animal models extensively. The findings offer valuable insights for future human clinical trials evaluating curcumin as a therapeutic supplement or nutraceutical in TBI management. Methods: Comprehensive literature searches were conducted across MEDLINE, Embase, Cochrane, Web of Science, and Google Scholar databases. These searches aimed to identify relevant manuscripts in all languages, utilizing the keywords "curcumin" and "traumatic brain injury." Results: The final quantitative analysis included 18 eligible articles corresponding to animal studies. The analysis revealed that curcumin significantly reduced inflammatory cytokines, including IL-1β ( p = 0.000), IL-6 ( p = 0.002), and TNF-α ( p = 0.000), across various concentrations, time points, and administration routes. Additionally, curcumin markedly enhanced the activity of oxidative stress markers such as SOD ( p = 0.000), Sir2 ( p = 0.000), GPx ( p = 0.000), and Nrf2 ( p = 0.000), while reducing MDA ( p = 0.000), 4-HNE ( p = 0.001), and oxyprotein levels ( p = 0.024). Furthermore, curcumin improved cerebral edema ( p = 0.000) and upregulated neuroprotective factors like synapsin I ( p = 0.019), BDNF ( p = 0.000), and CREB ( p = 0.000), without reducing mNSS ( p = 0.144). About autophagy and apoptosis, curcumin increased the activity of Beclin-1 ( p = 0.000) and Bcl-2 ( p = 0.000), while decreasing caspase-3 ( p = 0.000), the apoptosis index ( p = 0.000), and P62 ( p = 0.002). Conclusion: Curcumin supplementation positively affects traumatic brain injury (TBI) by alleviating oxidative stress and inflammatory responses and promoting neuroprotection. It holds potential as a therapeutic agent for human TBI. However, this conclusion necessitates further substantiation through high-quality literature and additional randomized controlled trials (RCTs). Systematic Review Registration: https://www.crd.york.ac.uk/prospero/. The registration number of PROSPERO: CRD42023452685.

Curcumin Provides Neuroprotection in Model of Traumatic Brain Injury Via the Nrf2-ARE Signaling Pathway

Activation of Nrf2–ARE Pathway in Brain after Traumatic Brain Injury

Role of NRF2 in protection against traumatic brain injury in mice

Tetrahydrocurcumin provides neuroprotection in rats after traumatic brain injury: autophagy and the PI3K/AKT pathways as a potential mechanism

Curcumin Suppress Inflammatory Response in Traumatic Brain Injury Via P38/mapk Signaling Pathway.

Curcumin in the treatment of inflammation and oxidative stress responses in traumatic brain injury: a systematic review and meta-analysis

Curcumin mitigates axonal injury and neuronal cell apoptosis through the PERK/Nrf2 signaling pathway following diffuse axonal injury

Curcumin alleviates neuroinflammation, enhances hippocampal neurogenesis, and improves spatial memory after traumatic brain injury

A highly bioavailable curcumin formulation ameliorates inflammation cytokines and neurotrophic factors in mice with traumatic brain injury

Melatonin stimulates antioxidant enzymes and reduces oxidative stress in experimental traumatic brain injury: the Nrf2-ARE signaling pathway as a potential mechanism.

Curcumin Modulates TLR4/NF-κB Inflammatory Signaling Pathway Following Traumatic Spinal Cord Injury in Rats

Luteolin provides neuroprotection in models of traumatic brain injury via the Nrf2-ARE pathway.

Curcumin Promotes Functional Recovery And Inhibits Neuronal Apoptosis After Spinal Cord Injury Through The Modulation Of Autophagy

The expression and distribution of Nrf2-ARE in rats models of traumatic brain injuries

Curcumin Produces Neuroprotective Effects Via Activating Brain-Derived Neurotrophic Factor/trkb-Dependent MAPK and PI-3K Cascades in Rodent Cortical Neurons

Tetrahydrocurcumin Reduces Oxidative Stress-Induced Apoptosis Via the Mitochondrial Apoptotic Pathway by Modulating Autophagy in Rats after Traumatic Brain Injury.

Curcumin in Vitro Neuroprotective Effects Are Mediated by P62/keap-1/Nrf2 and PI3K/AKT Signaling Pathway and Autophagy Inhibition.

Curcumin Alleviates Microglia-Mediated Neuroinflammation and Neuronal Ferroptosis Following Experimental Subarachnoid Hemorrhage by Modulating the Nrf2/HO-1 Signaling Pathway

Curcumin produces neuroprotective effects via activating brain-derived neurotrophic factor/TrkB-dependent MAPK and PI-3K cascades in rodent cortical neurons.

Neuroprotective mechanisms of curcumin against cerebral ischemia-induced neuronal apoptosis and behavioral deficits.

Curcumin Restrains Oxidative Stress of After Intracerebral Hemorrhage in Rat by Activating the Nrf2/HO-1 Pathway